Alloy Properties

Ecphora Capital's Deborah Hemingway, Ventas' Brian Newman And Oxford Properties Group's Chris Mundy

National View count: 62

‘It’s Going To Be A Grind’: Life Sciences Developers Don’t See Oversupply Problem Ending Soon

Sep 12, 2024 | Emily Wishingrad, Washington, D.C.

National Life Sciences

Phase 3 acquired 640 Memorial Drive in Cambridge from Alexandria Real Estate Equities.

Boston View count: 154

Alexandria Sells More Buildings In Cambridge, Waltham For $306M

Jan 3, 2024 | Taylor Driscoll, Boston

Boston Life Sciences

A rendering of the Boston Properties development in Kendall Square where AstraZeneca signed a 570K SF lease.

National View count: 99

Life Sciences Real Estate’s Biggest Deals Of 2023

Dec 7, 2023 | Patrick Sisson, National

National Life Sciences

Alexandria executive team at the New York Stock Exchange on May 16, 2022.

National View count: 97

Alexandria Real Estate President And CFO Resigns

Aug 18, 2023 | Taylor Driscoll, Boston

National Life Sciences

MIT Investment Management Co.'s Maureen McCaffrey, The Davis Cos.' Sean Coffey, HGA's Mark Allen, BXP's Patrick Mulvihill, Harvard Allston Land Co.'s Carl Rodrigues and Jacobs' Josh Rownd.

Boston View count: 63

Cambridge Seeing 'Demand Issue' As Life Sciences Slowdown Continues

Aug 3, 2023 | Taylor Driscoll, Boston

Boston Life Sciences

275 Grove St. In Newton, Massachusetts.

Boston View count: 50

Alexandria Continues Selling Spree With 2 More Boston-Area Deals

Jun 28, 2023 | Taylor Driscoll, Boston

Boston Life Sciences

Mayor Michelle Wu and the Boston Housing Authority celebrate the groundbreaking for Phase One of the Bunker Hill Housing redevelopment in Charlestown

Boston View count: 115

This Week's Boston Deal Sheet

Jun 20, 2023 | Taylor Driscoll, Boston

Boston Deal Sheet

266 Second Ave. in Waltham

Boston View count: 161

Alexandria Sells 5 Boston-Area Lab Buildings To TPG Joint Venture

Jun 14, 2023 | Taylor Driscoll, Boston

Boston Life Sciences